Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Benzoin is a resin derived primarily from Styrax benzoin and related trees, rich in benzoic acid, benzyl benzoate, and cinnamic acid esters that exert antimicrobial, anti-inflammatory, and wound-healing effects. Its bioactive triterpenoids and aromatic acids modulate inflammatory pathways and provide a protective barrier on mucosal and skin tissues.
Origin & History
Benzoin is a synthetic organic compound (2-hydroxy-1,2-diphenylethanone) prepared via condensation of benzaldehyde with potassium cyanide, belonging to the alpha-hydroxy ketones chemical class. While pure benzoin is laboratory-synthesized, compound tincture of benzoin (CTB) is derived from balsamic resins and used topically, though distinct from the pure compound.
Research Narrative (Provisional)
Clinical evidence for systemic benzoin use is extremely limited. One meta-analysis (PMCID: PMC12722693) examined Su He Xiang Pill containing benzoin resin for acute stroke (n=2537), showing improved clinical efficacy, though results cannot be attributed to benzoin alone. An older clinical study examined the colloidal benzoin reaction (PMID: 20315670).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Benzoin resin is not consumed as a food ingredient and thus has no conventional nutritional profile (negligible macronutrients, vitamins, or dietary minerals in therapeutic/topical doses). Its relevance lies entirely in its bioactive phytochemical composition. Primary bioactive compounds include: Benzoic acid (free and esterified, approximately 12–20% in Siam benzoin/Styrax tonkinensis; 6–12% in Sumatra benzoin/Styrax benzoin) — the principal antimicrobial and preservative constituent; Coniferyl benzoate (major component of Siam benzoin, ~60–70% by weight), a phenylpropanoid ester with antioxidant properties; Coniferyl cinnamate and sinapyl cinnamate (present in Sumatra benzoin, collectively ~10–30%); Sumaresinolic acid and siaresinolic acid (pentacyclic triterpenic acids, ~5–10% in Sumatra benzoin); Vanillin (approximately 1–3% in Siam benzoin), contributing fragrance and minor antioxidant activity; Styrene and styracin (cinnamyl cinnamate) in trace amounts (<2%); Benzaldehyde in trace volatile fractions (<0.5%). Bioavailability note: Topical and inhalational routes are primary delivery modes; transdermal absorption of benzoic acid is documented but limited quantitatively. Oral bioavailability data for whole resin constituents is sparse; benzoic acid when ingested is rapidly metabolized to hippuric acid via hepatic conjugation with glycine. No meaningful fiber, protein, or micronutrient content applicable.
Reported Mechanism (Provisional)
Benzoic acid and cinnamic acid derivatives in benzoin inhibit NF-κB signaling, suppressing pro-inflammatory cytokines including TNF-α and IL-6 at the transcriptional level. Benzyl benzoate acts as an antimicrobial agent by disrupting bacterial and fungal cell membrane integrity. Additionally, triterpenoid compounds such as sumaresinolic acid may modulate COX-2 enzyme activity, contributing to localized anti-inflammatory and analgesic effects at wound sites.
Clinical Narrative (Provisional)
A meta-analysis of 26 randomized controlled trials evaluating traditional Chinese medicine formulations containing benzoin reported improved neurological outcomes measured by NIHSS scores with a risk ratio of 1.21, though findings are confounded by high risk of bias and the multi-ingredient nature of the preparations. Compound tincture of benzoin (CTB) has been evaluated in dental clinical settings and deemed beneficial and safe for preventing alveolar osteitis following tooth extraction. Direct, benzoin-specific RCTs with adequate sample sizes remain lacking, meaning most evidence is either indirect or observational. Overall, the evidentiary base is preliminary and current clinical confidence should remain moderate at best.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.